Cannabis Committee - American Herbal Products Association (AHPA)

Technical Workshops

AHPA regularly presents in-person technical workshops to train the herbal products industry on the latest tools and methods that help ensure high-quality products and compliance with federal and state regulations.

Upcoming Events

Webinar: Supplement cGMP Basics for Hemp-CBD Companies

Hemp-CBD supplement companies should be cognizant of federal manufacturing requirements

Attend this webinar for an overview of dietary supplement current good manufacturing (cGMP) requirements for hemp-CBD products. Legal and industry experts will provide strategies and resources to comply and document compliance with these federal manufacturing requirements designed to ensure product quality and safety.
AHPA President Michael McGuffin delivers keynote at 26th Annual Hemp Industries Association Conference (HIACON)

AHPA President Michael McGuffin delivers keynote at 26th Annual Hemp Industries Association Conference (HIACON)

McGuffin discusses opportunities and challenges for those marketing hemp-CBD as a dietary supplement

AHPA President Michael McGuffin discussed opportunities and challenges for companies marketing hemp and cannabidiol (CBD) in products labeled as dietary supplements at the 26th Annual Hemp Industries Association Conference (HIACON) held in Charlotte, NC this week.

October 18, 2019 Meeting Minutes

Meeting of the Cannabis Committee

AHPA Members log in to download the meeting minutes.

CA Prop 65 Guidance for Hemp Products

Regulatory and liability implications of Proposition 65 for hemp and hemp-derived products

AHPA has published Guidance on California Proposition 65 and Hemp Products to educate the hemp industry about the regulatory and liability implications of Proposition 65 for hemp and hemp-derived products, including cannabidiol (CBD), sold in the State of California.

AHPA Hemp-CBD Status Report

Updated to cover recent FDA and USDA actions

To help the herbal products industry understand the evolving regulatory landscape for hemp and hemp-derived cannabidiol (CBD) products, AHPA has updated its free Hemp-CBD Status Report to include recent actions taken by the Food and Drug Administration (FDA) and the U.S. Department of Agriculture (USDA).

AHPA urges FDA to protect consumers by quickly clarifying hemp-CBD regulations

Existing supplement and food regulations are sufficiently robust for hemp-derived ingredients

The American Herbal Products Association (AHPA) urged the Food and Drug Administration (FDA) last week to protect consumers by quickly taking specific actions to clarify the regulatory status of hemp and hemp-derived ingredients used in dietary supplements and foods that contain cannabidiol (CBD).

Revised Hemp-CBD Status Report

How hemp and CBD companies are impacted by passage of the Farm Bill

Congress passed a Farm Bill in 2018 that included historic provisions to legalize hemp, the low THC cultivars of the Cannabis sativa L. species. This landmark legislation changes how hemp and hemp-derived products like cannabidiol (CBD) are regulated in the U.S. To help the herbal products industry understand the new regulatory landscape, AHPA has expanded this Status Report and to answer industry questions about the new legal landscape.

Sen. Wyden urges HHS-FDA to issue interim final rule for lawful use of CBD in food and dietary supplements

Sen. Wyden urges HHS-FDA to issue interim final rule for lawful use of CBD in food and dietary supplements

Sen. Wyden's request aligns with AHPA's hemp-CBD advocacy

Sen. Ron Wyden (D-OR), a co-author of the hemp provisions included in the 2018 Farm Bill, sent letters to Food and Drug Administration (FDA) Commissioner Ned Sharpless and Health & Human Services (HHS) Secretary Alex Azar urging the agencies to promptly create a regulatory pathway to use cannabidiol (CBD) as a food additive and as a dietary ingredient in dietary supplements.
More than 30 AHPA members and staff participate in the 2019 Day on the Hill

More than 30 AHPA members and staff participate in the 2019 Day on the Hill

AHPA partners with CRN, CHPA and UNPA to produce this unique advocacy opportunity

More than 30 AHPA member company executives—including company presidents, regulatory experts, and government relations executives—with a vested interest in legislative activity in Congress—flew in from across the nation, for a full day of networking and discussions with members of Congress and their staff. 

AHPA President Michael McGuffin urges FDA to use existing authority to create legal pathway for CBD products

AHPA President Michael McGuffin urges FDA to use existing authority to create legal pathway for CBD products

McGuffin recommends FDA issue interim final rule with an accelerated effective date

American Herbal Products Association (AHPA) President Michael McGuffin urged the Food and Drug Administration (FDA) to use existing authority to quickly create a lawful pathway -- including considering issuing a interim final rule -- for marketing of cannabidiol (CBD)-containing supplements and foods at a public meeting held by FDA in Silver Spring, MD.
RSS
1234

2019 Annual Fund Sponsors

  

AHPA appreciates the support of its sponsors, but does not endorse, recommend, or provide a warranty for any sponsor company, its products or services. AHPA has no responsibility for any transaction entered into with any of these companies.